ConductScience.org, home

Trial · NCT07553143

Effect of Preoperative Melatonin on Quality of Recovery After Elective Laparoscopic Cholecystectomy

NCT07553143, Not applicable, Recruiting, Armed Forces Medical Institute Bangladesh

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of Preoperative Melatonin on Quality of Recovery After Elective Laparoscopic Cholecystectomy. Trials, record NCT07553143. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07553143

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of Preoperative Melatonin on Quality of Recovery After Elective Laparoscopic Cholecystectomy
NCT number
NCT07553143
Status
Recruiting
Phases
Not applicable
Enrollment
84 participants, estimated
Lead sponsor
Armed Forces Medical Institute Bangladesh
Conditions
Laparoscopic Cholecystectomy, Postoperative Quality of Recovery, Preoperative Anxiety, Postoperative Sleep Quality, Opioid Consumption, Postoperative, PONV in Laparoscopic Cholocystectomies
Interventions
Melatonin (N-acetyl-5-methoxytryptamine), Placebo
First posted
2026-04-27
Last updated
2026-09-30

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryQuality of Recovery-15 (QoR-15) total score24 ± 2 hours after surgeryValidated 15-item patient-reported outcome. Range 0-150; higher = better recovery. MCID = 6.0 points.
SecondarySleep qualityMorning after surgery (approximately 16-24 hours post-op)
Measured using the Richards-Campbell Sleep Questionnaire (RCSQ), a 5-item visual analogue scale assessing depth, latency, awakenings, return to sleep, and overall quality of sleep. Composite score = mean of 5 items. Range 0-100; higher scores indicate better sleep quality.
SecondaryChange in preoperative anxietyFrom 60 minutes pre-surgery to immediately before induction
Measured as the change in the Visual Analogue Scale for Anxiety (VAS-A), a 100 mm horizontal analogue scale. Range 0-100 mm; 0 = no anxiety, 100 = worst possible anxiety. Change score = baseline VAS-A (T1) minus pre-induction VAS-A (T2). A positive value indicates reduction in anxiety; higher change scores indicate greater anxiolytic effect.
SecondaryTotal opioid consumption0-24 hours postoperativelyexpressed as intravenous morphine milligram equivalents (MME)
SecondaryIncidence of postoperative nausea and vomiting (PONV)0-24 hours postoperativelypostoperative nausea and vomiting (PONV) occurrence, Vomiting episodes, antiemetic rescue required
SecondaryTime to first rescue analgesic request0-24 hours postoperatively, measured in minutes from end of surgeryfirst rescue analgesic request within 24 hours postoperatively

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07553143

GET https://conductscience.org/api/trials/v1/NCT07553143/registered